Page last updated: 2024-09-04

docetaxel anhydrous and Peripheral Vascular Diseases

docetaxel anhydrous has been researched along with Peripheral Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amin, M; Bakos, K; Ben Abdallah, A; Frey, K; Haroutounian, S; Hincker, A; Kagan, L; Karlsson, P; Kosicka, K; Rao, L; Shah, R; Tan, B; Wagner-Johnston, N; Wildes, T	1

Trials

1 trial(s) available for docetaxel anhydrous and Peripheral Vascular Diseases

Article	Year
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study. Pain, 2019, Volume: 160, Issue:8 Topics: Aged; Analgesics; Antineoplastic Agents; Cross-Over Studies; Docetaxel; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxaliplatin; Paclitaxel; Pain Threshold; Peripheral Vascular Diseases; Predictive Value of Tests; Pregabalin	2019

Article

Year

Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study.

Pain, 2019, Volume: 160, Issue:8

Topics: Aged; Analgesics; Antineoplastic Agents; Cross-Over Studies; Docetaxel; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxaliplatin; Paclitaxel; Pain Threshold; Peripheral Vascular Diseases; Predictive Value of Tests; Pregabalin

2019